BioCryst Pharmaceuticals
BCRX
#4740
Rank
โ‚น129.65 B
Marketcap
โ‚น620.49
Share price
-3.33%
Change (1 day)
47.31%
Change (1 year)

Revenue for BioCryst Pharmaceuticals (BCRX)

Revenue in 2024 (TTM): โ‚น37.93 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น38.57 Billion. an increase over the revenue in the year 2023 that were of โ‚น27.58 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioCryst Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น38.66 B40.14%
2023 โ‚น27.58 B23.11%
2022 โ‚น22.41 B91.57%
2021 โ‚น11.69 B798.03%
2020 โ‚น1.30 B-62.59%
2019 โ‚น3.48 B141.15%
2018 โ‚น1.44 B-10.2%
2017 โ‚น1.60 B-10.2%
2016 โ‚น1.79 B-44.16%
2015 โ‚น3.20 B271.84%
2014 โ‚น0.86 B-19.45%
2013 โ‚น1.07 B-25.63%
2012 โ‚น1.43 B38.54%
2011 โ‚น1.03 B-62.83%
2010 โ‚น2.79 B-19.23%
2009 โ‚น3.46 B27.31%
2008 โ‚น2.71 B-2.76%
2007 โ‚น2.79 B916.33%
2006 โ‚น0.27 B3925.19%
2005 โ‚น6.83 M1672.84%
2004 โ‚น0.38 M-99.48%
2003 โ‚น74.39 M-12.57%
2002 โ‚น85.09 M-84.19%
2001 โ‚น0.53 B912.23%
2000 โ‚น53.18 M-54.57%
1999 โ‚น0.11 B-58.28%
1998 โ‚น0.28 B495.06%
1997 โ‚น47.15 M-49.55%
1996 โ‚น93.47 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น54.29 B 40.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น162.78 B 321.99%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น58.38 B 51.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.460 T 6,279.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.60 B-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.438 T 8,814.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น86.74 B 124.89%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA